Skip to main content

Misunderstanding of Findings Related to a Recent Article

Web Exclusives - Letters to the Editor

To the Editor,

This letter concerns our article “Treatment Patterns and Outcomes in Patients with Varicose Veins” (Am Health Drug Benefits, November 2016).1 We wish to correct a potential misunderstanding of our findings as described in the article, as communicated by Gary Owens, MD, in the Stakeholder Perspective, “Important Insights from Real-World Treatment Patterns and Outcomes for Varicose Veins,” an opinion piece related to our article.

Under the section labeled “Providers,” Dr Owens notes that the fact that a substantial percentage of the study patients received conservative therapy may be a reflection of the population being younger, female, and having less comorbidities. However, our findings, as stated in the article, actually show that it is the interventional cohort that is younger, more likely to be female, and more likely to have fewer comorbidities. Our inferred reasoning is that older patients, and those with more comorbidities, may have other urgent concerns than interventional treatment of varicose veins.

Rajiv Mallick, PhD

1. Mallick R, Raju A, Campbell C, et al. Treatment patterns and outcomes in patients with varicose veins. Am Health Drug Benefits. 2016;9(8):455-465.

Related Items
Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis
May 2020 Vol 13, No 2 published on May 20, 2020 in Letters to the Editor
Correspondence: Developing a Model Framework to Assess Cost of Therapy
Web Exclusives published on April 11, 2016 in Letters to the Editor, In the News
Correspondence: Cost of Treatment for Relapsed/Refractory Multiple Myeloma
December 2015 Vol 8, No 9 published on December 28, 2015 in Letters to the Editor
Last modified: August 30, 2021